Neuromuscular Blocking Agents - StatPearls - NCBI Bookshelf
2024年6月8日 · Neuromuscular blocking agents (NMBAs) are most effective when administered intravenously or intramuscularly. They are poorly absorbed if administered orally. The administration route is determined by the patient's clinical condition, desired action speed, and clinical effect duration.
Neuromuscular Blockade - StatPearls - NCBI Bookshelf
2023年11月13日 · Neuromuscular blocking agents (NMBAs) come in two forms: depolarizing neuromuscular blocking agents (eg, succinylcholine) and nondepolarizing neuromuscular blocking agents (eg, rocuronium, vecuronium, atracurium, cisatracurium, mivacurium).
Clinical use of neuromuscular blocking agents in anesthesia
Neuromuscular blocking agents (NMBAs) are usually administered during anesthesia to facilitate endotracheal intubation and/or to improve surgical conditions. NMBAs may decrease the incidence of hoarseness and vocal cord injuries during intubation, and can facilitate mechanical ventilation in patients with poor lung compliance [ 1-5 ].
Neuromuscular Blocking Agent - an overview - ScienceDirect
Neuromuscular blocking agents (NMBs) are substances that paralyze skeletal muscles by blocking nerve impulse transmission at the neuromuscular or myoneural (muscle-nerve) junction. You might find these chapters and articles relevant to this topic. Khorat Farooq, Jennifer M. Hunter, in Anaesthesia & Intensive Care Medicine, 2008.
List of Neuromuscular blocking agents - Drugs.com
What are Neuromuscular blocking agents? Neuromuscular blocking agents are potent muscle relaxants typically only used during surgery to prevent muscle movement. They are structurally related to acetylcholine (the main neurotransmitter in the body) and they cause muscle relaxation by binding to acetylcholine receptors postsynaptically (which ...
Neuromuscular Blocking - an overview | ScienceDirect Topics
Neuromuscular blocking agents (NMBAs) have no anesthetic or analgesic properties. They block transmission at the neuromuscular junction by competitive inhibition of acetylcholine, leading to paralysis of skeletal muscles.
Neuromuscular Blocking Agents General Statement (Monograph) - Drugs.com
Neuromuscular blocking agents are drugs that cause skeletal muscle relaxation and are classified as depolarizing or nondepolarizing (competitive) agents. Neuromuscular blocking agents are used to produce skeletal muscle relaxation during surgery after general anesthesia has been induced.
Neuromuscular Blocking Agents: An Overview (2024)
2024年11月19日 · Neuromuscular blocking agents (NMBAs) are a class of drugs that prevent nerve impulses from reaching muscles, effectively causing temporary paralysis of the skeletal muscles. These agents are commonly used during surgeries and in critical care settings to facilitate intubation and mechanical ventilation , ensure muscle relaxation, and improve ...
Neuromuscular Blocking Agent - an overview - ScienceDirect
When choosing an agent for use in the PICU population, the major issues include cardiovascular effects, metabolism, and cost. Since many of the patients in the PICU have some degree of hemodynamic instability, agents that cause excessive histamine release should be avoided.
Neuromuscular Blocking Agents: Use and Controversy in the …
2017年1月19日 · Neuromuscular blocking agents (NMBAs) play an important role in the management of a large number of hospital patients. In addition to their routine use in surgical anesthesia, NMBAs may be valuable in many new and evolving critical care situations.
- 某些结果已被删除一些您可能无法访问的结果已被隐去。显示无法访问的结果